{"schema_version":"secwatch.filing_event.v1","accession":"0001654954-23-012435","form_type":"8-K","ticker":"USBC","cik":"0001074828","company_name":"USBC, Inc.","filed_at":"2023-09-29T23:59:59+00:00","discovered_at":"2026-05-14T18:03:33.082341+00:00","generated_at":"2026-06-10T06:46:55.264564+00:00","sec_items":["1.01","7.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"Know Labs prices $7M public offering of 28M shares at $0.25 per share","bullets":["Firm commitment underwritten offering of 28,000,000 common shares at $0.25/share, gross proceeds $7M.","Net proceeds to Know Labs after underwriting discounts and expenses approximately $6.39M.","Underwriters granted 30-day over-allotment option for up to 4,200,000 additional shares.","Issued representatives' warrants to Boustead and Benchmark for 1,960,000 shares at $0.25, exercisable until Sept 2028.","Proceeds intended for product development, clinical studies, IP, working capital, and G&A."],"urls":{"canonical":"https://secwatch.observer/filing/0001654954-23-012435","json":"https://secwatch.observer/filing/0001654954-23-012435.json","markdown":"https://secwatch.observer/filing/0001654954-23-012435.md","text":"https://secwatch.observer/filing/0001654954-23-012435.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1074828/000165495423012435/0001654954-23-012435-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1074828/000165495423012435/knwn_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-10T06:46:55.264564+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"f54c4b24cab48ac0c24de0392c86284ad51e6419","claim":"USBC, Inc. entered into Underwriting Agreement with Boustead Securities, LLC and The Benchmark Company, LLC as representatives of the underwriters valued at approximately $6.39 million (effective 2023-09-26).","evidence_excerpt":"On September 26, 2023, Know Labs, Inc. (the “ Company ”) entered into an underwriting agreement (the “ Underwriting Agreement ”) with Boustead Securities, LLC and The Benchmark Company, LLC as representatives (the “ Representatives ”) of the underwriters named on Schedule 1 thereto (the “ Underwriters ”), relating to the Company’s registered public offering (the “ Offering ”) of shares of the Company’s common stock, par value $0.001 per share (the “ Common Stock ”).","evidence_source":"SEC 8-K Item 1.01/1.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1074828/000165495423012435/0001654954-23-012435-index.htm","confidence":0.9,"family_label":"Material Agreements","details":[{"label":"Action","value":"entry"},{"label":"Agreement","value":"underwriting"},{"label":"Counterparty","value":"Boustead Securities, LLC and The Benchmark Company, LLC as representatives of the underwriters"},{"label":"Value","value":"approximately $6.39 million"},{"label":"Effective","value":"2023-09-26"}],"fact_type":"material_agreement"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}